
Blog


PNI Scientists Explore Using Psychedelics to Treat Alcohol, Drug Disorders
by Guest Author
Psilocybin and many other psychedelics are broadly prohibited under federal law. But US researchers at the PNI's Pacific Treatment & Research In Psychedelics (TRIP) program have been legally scrutinizing their use in a score of clinical trials.
PNI Founders’ Message 2023
by Daniel F. Kelly
At Pacific Neuroscience Institute® (PNI) we achieved many milestones in 2022 and continue to make positive impacts in neuroscience clinical care, research, and education.
PNI Publishes First-Ever Paper on Psychedelics in Neurosurgery and Neuro-oncology Literature
by PNI Experts
After a decades-long pause, psychedelics are once again being investigated for their transdiagnostic treatment potential. Discover the future of psychedelics in neurosurgery and neuro-oncology with experts from Pacific Neuroscience Institute ® (PNI).
What is Ketamine Therapy?
by Keith Heinzerling
Ketamine is approved for use at high doses as an anesthetic in the operating room. Although not FDA-approved, lower dose “sub-anesthetic” ketamine injections are used “off-label” to treat depression, pain, and other mental health/substance use disorders. In recent times, there have been many factors contributing...
Neurology and Neurosurgery High Level Performance Recognized at Providence Hospitals
by Zara Jethani
Pacific Neuroscience Institute teams in Neurology and Neurosurgery contribute to High Performing Hospitals in US News & World Report rankings.
Pacific Neuroscience Institute Physicians Named “L.A.’s Top Doctors” of 2022
by Zara Jethani
This year, six of Pacific Neuroscience Institute’s physicians were included in Los Angeles Magazine’s April 2022 roster of “L.A.’s Top Doctors.”
Psilocybin Clinical Trial for Depression Launches at Pacific Neuroscience Institute
by Zara Jethani
Pacific Neuroscience Institute (PNI) located at Providence Saint John's Health Center, has activated a new psilocybin clinical trial and has begun participant enrollment.
PNI Founders’ Message 2022
by Daniel F. Kelly
At Pacific Neuroscience Institute, we are looking forward to what lies ahead with fresh excitement. Neurological diseases do not stop and neither have we.
The Role of Clinical Trials at PNI
by Amelia Garrison
Clinical trials are research studies that play a critical role in the advancement of clinical and medical knowledge about disease. At Pacific Neuroscience Institute (PNI), there are a number of upcoming and ongoing trials for patients with various neurological conditions.
Integrating Lifestyle Strategies into the Care of Neurologic Disease – Brain Health CME Course
by Zara Jethani
Pacific Neuroscience Institute announces an exciting brain health CME course for practicing clinical professionals. Registration is open.
Last updated: November 19th, 2021